Can't agree more Dommy...
Many on here herald SI. Know a bloke who has been integral to the science who does not hold that view - and this is not his opinion. It is his 1st hand experience.
The issue with SI is however a Board responsibility. Of how they make their decisions, (ie: how easily swayed/not they are by their CEO), is something I have no knowledge of.
However, significant leadership questions (of Board & CEO) must now be asked, answered and then ACTIONED.
Ann: Update on BLA for Graft Versus Host Disease, page-267
-
- There are more pages in this discussion • 751 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
99.0¢ |
Change
0.010(1.02%) |
Mkt cap ! $1.130B | |||
| Open | High | Low | Value | Volume |
| 99.5¢ | $1.02 | 98.5¢ | $5.507M | 5.501M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9996 | 99.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 99.5¢ | 18069 | 3 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |